Archives
Rational Design of NIR-II IR-1061 Liposomes for Deep Vascula
2026-04-28
Rational Design of NIR-II IR-1061 Liposomes for Deep Vascular Imaging
Study Background and Research Question
Fluorescence imaging (FI) has become a cornerstone in biomedical research, offering non-invasive, high-sensitivity visualization for applications ranging from DNA sequencing to cell tracking. Of particular interest is the near-infrared II (NIR-II; 1000–1700 nm) spectral window, which features reduced photon scattering and low tissue autofluorescence, thus permitting deeper tissue penetration and higher signal-to-noise ratios for in vivo imaging (paper). However, the development of biocompatible, high-performance NIR-II fluorescent dyes for in vivo imaging remains challenging. Inorganic NIR-II materials like quantum dots and rare-earth nanoparticles offer strong optical properties, but poor excretion kinetics and long-term retention limit their clinical potential. Organic small-molecule fluorophores, such as IR-1061—a hydrophobic cyanine dye with a peak emission at 1064 nm—present a promising alternative due to better biocompatibility and safety profiles (paper). Nonetheless, their solubility, aggregation behavior, and interaction with biological environments must be carefully engineered to maximize their performance in vivo. The central research question addressed was: How can the encapsulation environment—specifically liposome charge and IR-1061 loading—be tuned to maximize NIR-II fluorescence output and circulation performance for vascular imaging?Key Innovation from the Reference Study
The study by Yu et al. introduces a rational design strategy for constructing IR-1061-based NIR-II fluorescent nanosystems, focusing on liposomal encapsulation as a tunable platform (paper). The pivotal innovation is the systematic analysis of how phospholipid charge and dye concentration in liposomes affect the encapsulation efficiency, aggregation state, and ultimately, fluorescence yield of IR-1061 in biological environments. Most notably, the authors engineered an anionic liposomal formulation—IR1061-ALP-N3—that achieves both high fluorescence intensity and extended vascular circulation, supporting high-resolution angiographic imaging in vivo. This approach moves beyond generic dye encapsulation by dissecting how electrostatic interactions between IR-1061 and liposome components control the dye's photophysical properties, enabling the design of nanosystems with optimal performance for deep-tissue and vascular imaging.Methods and Experimental Design Insights
The researchers synthesized liposomes with varying phospholipid charges (anionic, cationic, and neutral) and loaded them with different concentrations of IR-1061. The encapsulation efficiency of IR-1061 was quantified, and the fluorescence properties were measured as a function of both liposome charge and dye loading. Additionally, the aggregation state of IR-1061 within liposomes was evaluated to understand the relationship between concentration, molecular conformation, and fluorescence output (paper). In vivo fluorescence imaging was performed using the optimized IR1061-ALP-N3 liposomes in mouse models. The spatial resolution, circulation time, and angiography quality were assessed over prolonged imaging sessions, enabling the authors to link nanosystem design parameters with functional imaging outcomes.Protocol Parameters
- fluorophore | IR-1061 | in vivo NIR-II imaging | hydrophobic cyanine dye with 1064 nm emission peak; QY ~1.7% | paper
- liposome charge | anionic > neutral > cationic | encapsulation efficiency and fluorescence yield | anionic liposomes maximize encapsulation and minimize aggregation-related quenching | paper
- IR-1061 loading concentration | moderate (avoiding aggregation) | in vivo fluorescence intensity | excess loading induces aggregation, reducing fluorescence; optimal range based on liposome volume and charge | paper
- solvent for dye preparation | DMSO (≥25.65 mg/mL) | stock solution preparation | IR-1061 is soluble in DMSO, insoluble in water and ethanol | product_spec
- storage conditions | -20°C, desiccated, avoid long-term solutions | stock and nanosystem stability | preserves IR-1061 fluorescence and integrity | product_spec
Core Findings and Why They Matter
The study's core findings demonstrate that the physicochemical environment of IR-1061 within liposomes is critical for achieving efficient NIR-II fluorescence:- Electrostatic Interactions: Anionic liposomes provided the highest encapsulation efficiency for IR-1061, while cationic liposomes performed worst—directly correlating with the charge-dependent affinity and stabilization of the dye (paper).
- Aggregation-Dependent Quenching: At higher loading concentrations, IR-1061 transitioned from a free to an aggregated state within liposomes, markedly reducing fluorescence intensity. Therefore, fine-tuning the dye-to-lipid ratio is essential for maximizing signal output (paper).
- Superior Imaging Performance: The optimized IR1061-ALP-N3 system enabled clear, high-resolution systemic angiography in mice, with fluorescence signals persisting for over 16 hours, underscoring its utility for long-circulating vascular imaging (paper).
- Clinical Translation Potential: Compared to inorganic nanomaterials, small-molecule organic dyes like IR-1061 offer faster clearance and improved biocompatibility, addressing a key hurdle for future clinical adoption (paper).
Comparison with Existing Internal Articles
Internal literature further contextualizes the advances of this study:- "Maximizing NIR-II Fluorescence: IR-1061 Liposome Design Advances" reinforces the central finding that liposome charge and dye aggregation state are critical for optimizing IR-1061 performance in vivo, echoing the reference paper's design rules.
- "Polystyrene Nanoparticles Enhance IR-1061 NIR Imaging for Deep Tissue" describes an alternative encapsulation strategy—using polymeric nanoparticles—which addresses similar challenges of dye solubility and aggregation but with different material constraints and pharmacokinetics.
- "IR-1061 as a Benchmark Near Infrared Fluorescent Dye for Deep Imaging" discusses assay decision-making and solvent compatibility, confirming that DMSO is the preferred solvent for IR-1061 and underscoring the practical considerations highlighted in the reference study.
Limitations and Transferability
While the study provides robust evidence for the role of liposome charge and loading concentration in controlling IR-1061 fluorescence, several limitations and considerations for broader application exist:- The precise dye-to-lipid ratios yielding optimal fluorescence may vary depending on liposome size, composition, and preparation protocol, necessitating workflow-specific optimization (paper).
- Results are primarily validated in murine vascular imaging models; further studies are needed to confirm performance in other tissues, disease models, and larger animals (workflow_recommendation).
- The long-term safety and clearance characteristics of IR-1061-loaded liposomes, while promising for biocompatibility, require additional investigation for clinical translation (paper).